Affiliation:
1. Trent/Fleming School of Nursing, Trent University, Canada
2. Department of Adult Health and Critical Care, College of Nursing, Sultan Qaboos University, Muscat, Sultanate of Oman
Abstract
Background: In Egypt as elsewhere, patients with schizophrenia and their families confront unique obstacles. This study examined the views of important stakeholders’ on the feasibility, approval, and obstacles of family intervention programs for schizophrenia in Egypt to address these issues. Objective: The aim of the study was to investigate the perspectives of stakeholders regarding the feasibility, acceptability, and obstacles associated with providing family intervention for schizophrenia in Egypt. Methods: The research took place at El-Maamoura Hospital in Alexandria and included a total of 37 participants. These participants were divided into seven focus groups, with 25 individuals being health professionals and the remaining 12 individuals being caregivers. Concurrently, data collection and analysis were carried out using the qualitative research method, employing the framework analysis to process the transcripts. Results: The participants highlighted the importance of families feeling accepted and well-informed regarding the nature of the illness. In conclusion, the participants suggested making changes to the intervention’s content by incorporating details about the illness, providing emotional support, and including culturally appropriate coping mechanisms. Conclusion: In conclusion, it is determined by the study that before implementing family intervention for schizophrenia, it is crucial to make cultural adjustments to ensure its acceptability. The findings of the study offer valuable insights for the development and execution of family intervention programs for schizophrenia in Egypt. Implication for Clinical Practice: It is crucial to culturally adapt a modified family interventions to cater to the cultural requirements of families and healthcare professionals in Egypt, as this could potentially result in improved outcomes for patients diagnosed with schizophrenia and their families.